emtricitabine / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 23 Diseases   7 Trials   7 Trials   302 News 
12 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
emtricitabine / Generic mfg.
NCT03675815: Body Composition Sub-study of the D2EFT Trial

Completed
4
155
RoW
Darunavir (DRV) 800 milligram (MG) Oral Tablet, Prezista, Ritonavir 100 MG Oral Tablet, Norvir, RTV, N(t)RTIs, Nucleoside/nucleotide reverse transcriptase inhibitors [N(t)RTIs], Dolutegravir 50 MG Oral Tablet, Tivicay, DTG, TDF 300 MG Oral Tablet, tenofovir disoproxil fumarate, Viread, 3TC 300 MG Oral Tablet, lamivudine, FTC 200 MG Oral Cap, Emtriva, emtricitabine
Kirby Institute
HIV Infections
01/24
01/24
DOLCE, NCT04880395: Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3

Completed
4
230
RoW
Intervention Arm: dolutegravir/lamivudine, Dovato, Comparator ARM: TDF/XTC plus Dolutegravir (XTC stand for lamivudine OR emtricitabine)
Fundación Huésped, ViiV Healthcare, Federal University of Bahia
HIV-1-infection
05/24
05/24
MAFALDA-R, NCT05898841: Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load

Active, not recruiting
4
75
Europe
Dolutegravir (DTG) 50 mg/day + Rilpivirine (RPV) 25mg per day, Tenofovir disoproxil fumarate (TDF) 245 mg per day or Tenofovir alafenamide (TAF) 25 mg per day + Emtricitabine (FTC) 200 mg per day + Rilpivirine 25 mg per day, Continue with their previous treatment. Any previous HAART that does not contain Rilpivirine.
Fundacion SEIMC-GESIDA
HIV Infections, Fatty Liver Disease
01/25
04/25
2021-000243-50: Understanding the Impact of HIV-DNA resistance mutations detected by NGS in Simplificationstrategies to 2-Drug Regimens for patients virologically suppressed with previous failures and/orprevious resistance mutations: a prospective multi-centre intervention study (INS-2DR) Impatto delle mutazioni di resistenza rilevate su HIV-DNA con NGS nelle strategie di Semplificazione a regimi a due farmaci in pazienti HIV+ virologicamente soppressi con pregressi fallimenti virologici e/o pregresse mutazioni di resistenza: uno studio prospettico interventistico multi-centrico (INS-2DR)

Not yet recruiting
3
210
Europe
Lamivudina, Pifeltro, Emtriva, Juluca, Janssen-Cilag International NV, Tivicay, Dovato, [-], Tablet, Film-coated tablet, Capsule, hard, Coated tablet, Lamivudina, Pifeltro, Emtriva, Juluca, EDURANT, Tivicay, Dovato
ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE "LAZZARO SPALLANZANI", Ministero della salute
HIV infection Infezione da HIV, HIV infection Infezione da HIV, Diseases [C] - Virus Diseases [C02]
 
 
2005-000005-65: Comparación de dos alternativas de combinación de nucleósidos, en pacientes infectados por el HIV-1 con supresión virológica mantenida y en tratamiento con lamivudina (3TC). Estudio aleatorizado, multicéntrico y abierto.

Ongoing
3
300
Europe
Kivexa, Viread, Emtriva, GI 265235 + GR 109714, Viread, Emtriva, Viread, Emtriva
Servicio de Infecciones. Hospital Clínic de Barcelona
Chronic HIV infection
 
 
2016-003741-29: Study of the use of anti_HIV drugs with reduced neuronal toxicity (including maraviroc) in patients with neurocogntive disorders Utilizzo di farmaci per il trattamento dell'infezione da HIV a ridotta tossicit¿ sui neuroni (incluso maraviroc) in pazienti con disturbi neurocognitivi

Not yet recruiting
3
76
Europe
CELSENTRI, EMTRIVA, MARAVIROC, EMTRIVA, Coated tablet, CELSENTRI - 300 MG COMPRESSA RIVESTITA CON FILM - USO ORALE BLISTER (PVC/ALU) 60 COMPRESSE, REZOLSTA - 800 MG/ 150 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE-FLACONE (HDPE)- 30 COMPRESSE, EMTRIVA - 30 CAPSULE RIGIDE IN FLACONE DA 200 MG
A.S.L. TO 2, Viiv Healthcare
HIV-infection, HIV-associated neurocognitive disorders Infezione da HIV, disordini neurocognitivi HIV-correlati, HIV-infection with neurocognitive problems Infezione da HIV con problemi neurocognitivi, Diseases [C] - Virus Diseases [C02]
 
 
2020-001867-94: Effet du tenofovir/emtricitabine en cure courte sur la clairance virale chez des patients infectés par le SARS-CoV2 (COVID-19) non hospitalisés Effet du tenofovir/emtricitabine en cure courte sur la clairance virale chez des patients infectés par le SARS-CoV2 (COVID-19) non hospitalisés

Not yet recruiting
3
180
Europe
Emtricitabine/Ténofovir disoproxil Mylan, Tablet, Emtricitabine/Ténofovir disoproxil Mylan
CHU CAEN Normandie, CHU CAEN
patients atteints d’une infection SARS-CoV2 non hospitalisés patients atteints d’une infection SARS-CoV2 non hospitalisés, Patients atteints d’une infection SARS-CoV2 non hospitalisés Patients atteints d’une infection SARS-CoV2 non hospitalisés, Diseases [C] - Virus Diseases [C02]
 
 
ELDORADO, NCT06203132: DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection

Not yet recruiting
3
610
Europe, RoW
Doravirine + tenofovir DF + lamivudine, Delstrigo, Dolutegravir + tenofovir DF + lamivudine or emtricitabine
ANRS, Emerging Infectious Diseases, MSD France
HIV-1-infection
11/26
11/27
LINE-AD, NCT04500847: Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

Recruiting
1
35
US
Emtriva Capsule, Emtricitabine, Placebo, Capsule manufactured to mimic Emtriva
Butler Hospital, Alzheimer's Association, Brown University, The Miriam Hospital
Alzheimer Disease, Early Onset, Mild Cognitive Impairment, Moderate Dementia
03/25
03/25
ARTAN-C19, NCT04712357: Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19

Recruiting
N/A
219
RoW
Vitamin C 500 MG Oral Tablet, Tenofovir disoproxyl fumarate 300 MG Oral Tablet, Tenofovir disoproxyl fumarate 300 MG plus emtricitabine 200 MG Oral Tablet
Universidade Federal do Ceara, Conselho Nacional de Desenvolvimento Científico e Tecnológico, São José Hospital for Infectious Diseases - HSJ, Central Laboratory of Public Health of Ceará - Lacen-CE
Covid19
01/22
01/23
NCT05222945: A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide

Not yet recruiting
N/A
34
Europe
Biopsies and bloood samplings
ANRS, Emerging Infectious Diseases, Gilead Sciences
HIV-1-infection
10/25
10/25
SeVIHPrEP, NCT05492565: Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis

Enrolling by invitation
N/A
500
Europe
Tenofovir Disoproxil Fumarate 300 MG Oral Tablet, Emtricitabine 200 MG Oral Tablet
Hospitales Universitarios Virgen del Rocío, Instituto de Biomedicina de Sevilla
HIV Infection Primary, Hepatitis, Viral, Human, Sexually Transmitted Infections, Excluding HIV and Hepatitis
12/29
12/30

Download Options